foxo4-dri peptide senolytic 2023 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis ES2 rapidly destroys TP53-FOXO4 foci
ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Buy FOXO4 DRI 10mg Third Party Tested BioEdge Peptides Buy FOXO4 DRI Greece PharmaGrade.Store
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



